Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1497, 2005-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Which discounting method best for pharmacoeconomic analyses?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 482, 2005-01 ,pp. :
Access to resources
Recommend
Is the use of the `transfer to utility' method valid in economic analyses?
Inpharma, Vol. 1, Iss. 1457, 2004-01 ,pp. :
Measuring indirect costs: which method's best?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 280, 2000-01 ,pp. :
Which Antifungal Agent for Onychomycosis?: A Pharmacoeconomic Analysis
By Joish V.N.
PharmacoEconomics, Vol. 19, Iss. 10, 2001-01 ,pp. :
Preventing CMV infection - which strategy's best?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 283, 2000-01 ,pp. :